Samtidig administration af etoricoxib og rifampicin, en potent CYP- enzyminduktor, medførte et fald på 65% i etoricixibs plasmakoncentration.
Co-administration of etoricoxib with rifampicin, a potent inducer of CYP enzymes, produced a 65% decrease in etoricoxib plasma concentrations.